title: Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantation for chronic myeloid leukaemia.
authors.forename: Anna Z
authors.initials: AZ
authors.lastname: Castleton
authors.forename: Diana
authors.initials: D
authors.lastname: Brazma
authors.forename: Julie
authors.initials: J
authors.lastname: Howard-Reeves
authors.forename: Anastasios
authors.initials: A
authors.lastname: Chanalaris
authors.forename: Julie
authors.initials: J
authors.lastname: Glanville
authors.forename: Dean
authors.initials: D
authors.lastname: Nizetic
authors.forename: Ronjon
authors.initials: R
authors.lastname: Chakraverty
authors.forename: Elisabeth P
authors.initials: EP
authors.lastname: Nacheva
mesh_terms: D000328:Adult; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects*; D005260:Female; D005784:Gene Amplification; D006801:Humans; D007621:Karyotyping; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D015470:Leukemia, Myeloid, Acute / Q000209:etiology*; D008297:Male; D009857:Oncogenes; D014019:Tissue Donors